Table 3.
Medication profile of heart failure patients based on anemia status
| Variable | Non – anemic (215) | Anemic (155) | P – value |
|---|---|---|---|
| Diuretics n (%) | 199 (92.56%) | 135 (87.10%) | 0.080 |
| Spironolactone n (%) | 148 (68.84%) | 100 (64.52%) | 0.383 |
| ACEI n (%) | 113 (52.56%) | 65 (41.94%) | 0.044* |
| Beta Blocker n (%) | 105 (48.84%) | 77 (49.68%) | 0.873 |
| Digoxin n (%) | 49 (22.79%) | 43 (27.74%) | 0.277 |
| CCB n (%) | 14 (6.51%) | 17 (10.97%) | 0.127 |
| Antiplatelet n (%) | 45 (20.93%) | 36 (23.23%) | 0.598 |
| Anticoagulants n (%) | 48 (30.97%) | 33 (21.29%) | 0.812 |
| Statin n (%) | 34 (15.81%) | 27 (17.42%) | 0.681 |
ACEI Angiotensin converting enzyme inhibitor, CCB calcium channel blocker
*p < 0.05